ISTH interim guidance on recognition and management of coagulopathy in COVID-19

J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Betacoronavirus*
  • Biomarkers / blood*
  • Blood Coagulation Disorders* / blood
  • Blood Coagulation Disorders* / diagnosis
  • Blood Coagulation Disorders* / etiology
  • Clinical Laboratory Techniques
  • Coronavirus Infections / blood
  • Coronavirus Infections / complications*
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / epidemiology
  • Fibrin Fibrinogen Degradation Products
  • Humans
  • Pandemics
  • Platelet Count
  • Pneumonia, Viral / blood
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / epidemiology
  • Prothrombin Time

Substances

  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D

Supplementary concepts

  • COVID-19
  • COVID-19 diagnostic testing
  • severe acute respiratory syndrome coronavirus 2